King Pharma Sues Sandoz Over Generic EpiPen

By Julie Zeveloff · July 16, 2010, 12:25 PM EDT

EpiPen maker King Pharmaceuticals Inc. has lodged a complaint against Novartis AG's Sandoz Inc. unit, seeking to block the generic-drug maker from making and selling its own version of the epinephrine...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Recent Articles By Julie

October 13, 2010
Cobalt Released From Sepracor Suit Over Sleep Drug
October 07, 2010
Pfizer Recalls 191,000 Lipitor Bottles Due To Odor
October 07, 2010
Endo, Watson Settle Litigation Over Opana ER Generic
October 05, 2010
Teva Sues Mylan, Others Over Proposed Azilect Generic
September 30, 2010
Novartis Contact Lens Patent Invalid, UK Court Affirms
September 23, 2010
US, EU Regulators Ban GSK's Avandia In Most Cases
August 11, 2010
Conceptus Falsely Marked Sterilization Kit, Rival Says
July 27, 2010
St. Jude Goes After Volcano Over Guide Wire Patents
July 26, 2010
Wyeth Bests Pa. Fen-Phen Hypertension Suit
July 15, 2010
Latham Reps Carlyle Group In $3.8B NBTY Acquisition